The Future of AI Design in Medical Devices can you find references and pros and cons on using this topic in a dissertation

Argument (concise) While the proposed dissertation topic is timely and interdisciplinary, it faces substantive limitations that can weaken its theoretical clarity, empirical feasibility, and normative contribution if not tightly scoped. 1. Epistemic diffusion and lack of focus - The topic spans algorithmic design, human–device interaction, regulation, ethics, and socioeconomics. Without narrowing to a specific class of devices, a jurisdiction, or a single problem (e.g., validation of continuous-learning SaMD), the project risks producing a descriptive survey rather than a coherent, original argument or empirical finding. See Popper on the need for falsifiable, focused hypotheses (Popper, The Logic of Scientific Discovery, 1959). 2. Rapid obsolescence of technical and regulatory claims - AI methods, approvals, and policy frameworks evolve quickly (FDA AI/ML Action Plan, 2021; EU AI Act drafts). A dissertation with broad claims about "the future" may be outdated before completion, limiting long-term scholarly impact. To avoid this, research should target enduring conceptual problems (e.g., validation epistemology, accountability frameworks) rather than transient technologies. 3. Empirical constraints and reproducibility concerns - Much cutting‑edge AI in medical devices is commercial and proprietary. Restricted data, model access, and non-disclosure agreements can prevent reproducible experiments or independent verification, undermining scientific credibility (Ghassemi et al., Lancet Digital Health, 2021). This makes strong empirical claims difficult unless partnerships or open datasets are secured. 4. Methodological overstretch and supervisory demands - To address the full scope competently requires deep technical, clinical, legal, and ethical expertise. Achieving that breadth within a single doctoral timeline risks superficial treatment across domains. A more defensible project focuses on one domain and engages interdisciplinary literature to contextualize findings rather than attempt mastery of all areas. 5. Normative ambiguity and policy recommendations - Proposing regulatory or ethical prescriptions for AI design presumes settling contested value judgments (trade-offs between safety, innovation, and access). Without a clear normative framework, recommendations may lack justification or conflict with stakeholders’ priorities, reducing practical uptake (Floridi et al., AI4People, 2018). 6. Measurement difficulties for human factors and outcomes - Claims about clinician trust, workflow integration, or patient outcomes require longitudinal, often costly studies. Short-term or lab-based usability work may not generalize to clinical practice, limiting the strength of applied conclusions (Kelly et al., BMC Medicine, 2019). Conclusion and remedy The topic is important but, as stated, is too broad and vulnerable to empirical and normative pitfalls. The dissertation will be stronger if it narrows to a tractable, high-impact question—for example: "Regulatory design requirements for continuous‑learning imaging SaMD under FDA and EU frameworks," or "Human-centered explainability practices that improve clinician adoption of AI-assisted radiology tools." Narrowing preserves relevance while ensuring methodological rigor, reproducibility, and lasting contribution. Key citations - FDA. "AI/ML-Based Software as a Medical Device (SaMD) Action Plan." 2021. - Ghassemi, M., et al. "Practical guidance on artificial intelligence for health‑care data." Lancet Digital Health, 2021. - Kelly, C. J., et al. "Key challenges for delivering clinical impact with artificial intelligence." BMC Medicine, 2019. - Floridi, L., et al. "AI4People—An Ethical Framework for a Good AI Society." Minds and Machines, 2018. - Popper, K. "The Logic of Scientific Discovery." 1959. If you want, I can convert this critique into a brief set of actionable changes: a narrowed research question, a 3‑chapter outline, and recommended data sources.Title: A Short Argument Against "The Future of AI Design in Medical Devices — Pros, Cons, and Key References" Argument (concise) While examining "The Future of AI Design in Medical Devices" is timely, framing a dissertation around this broad topic risks producing work that is diffuse, quickly outdated, and difficult to substantiate empirically. The field’s rapid technological and regulatory flux means conclusions may lose relevance over the multi‑year life of a doctoral project. Much critical data and deployed algorithms are proprietary, limiting reproducibility and rigorous evaluation. The topic’s necessary interdisciplinarity—spanning machine learning, clinical validation, human factors, regulatory law, and ethics—demands supervisory breadth and technical depth that many programs cannot provide, increasing the chance of superficial treatment of key areas. Finally, core problems (e.g., continuous‑learning models, distribution shift, liability) are unsettled and politically contested, making it hard to produce definitive, generalizable recommendations rather than contingent, jurisdiction‑specific guidance. Concise reasons to reconsider or narrow the topic - Rapid obsolescence: Regulations and methods evolve fast; a broad dissertation may become dated. - Data access barriers: Proprietary models and datasets impede reproducible empirical work. - Validation complexity: Demonstrating clinical safety and generalizability is technically and ethically demanding. - Supervisory and skill demands: Requires cross‑domain expertise that may exceed available support. - Limited actionable outcomes: Broad policy or design recommendations risk being too general to influence practice. Suggested mitigation (very brief) - Narrow scope (single device class, one jurisdiction, or one regulatory question). - Focus on a tractable empirical case study or produce a methodological contribution (e.g., a validation protocol). - Partner with clinicians or industry to secure data and realistic constraints. Key references for the critique - FDA. "Artificial Intelligence and Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan." 2021. https://www.fda.gov/media/145022/download - Hernandez‑Boussard, T., et al. "Hidden in plain sight—reconsidering the regulatory framework for software as a medical device." NEJM, 2020. - Benjamens, S., Dhunnoo, P., & Mesko, B. "The state of artificial intelligence‑based FDA‑approved medical devices and algorithms." NPJ Digital Medicine, 2020. - Wiens, J., et al. "Do no harm: a roadmap for responsible machine learning for health care." Nature Medicine, 2019. If you want, I can convert this into a one‑page critique for your dissertation proposal or suggest a narrowly focused alternative research question and outline.